CT-011
Showing 1 - 25 of 7,457
Multiple Myeloma Trial in Boston, Haifa (CT-011, Dendritic Cell Fusion Vaccine)
Active, not recruiting
- Multiple Myeloma
- CT-011
- Dendritic Cell Fusion Vaccine
-
Boston, Massachusetts
- +2 more
Sep 5, 2022
Breast Tumor, Metastatic Breast Cancer, Rb+ Breast Cancer Trial in Philadelphia ([18F]FLT, PET/CT, ribociclib)
Active, not recruiting
- Breast Neoplasm
- +2 more
- [18F]FLT
- +3 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Hospital
Aug 16, 2022
Social Anxiety Disorder Trial in Coimbra (Cognitive Therapy, Compassion-focused Therapy, Acceptance and Commitment Therapy)
Active, not recruiting
- Social Anxiety Disorder
- Cognitive Therapy
- +2 more
-
Coimbra, PortugalFaculdade de Psicologia e Ciências da Educação - Universidade de
Jul 29, 2022
Recurrent Endometrial Serous Adenocarcinoma Trial in Columbus (procedure, biological, drug)
Not yet recruiting
- Recurrent Endometrial Serous Adenocarcinoma
- Biospecimen Collection
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
May 12, 2023
Prostatic Tumors Trial in Augusta (CT-011 (Anti-PD1 Antibody), Sipuleucel-T (Provenge), Cyclophosphamide)
Terminated
- Prostatic Neoplasms
- CT-011 (Anti-PD1 Antibody)
- +2 more
-
Augusta, GeorgiaGeorgia Regents University
Jun 18, 2019
Pancreatic Tumors, Cancer of the Pancreas, Tumors Pancreatic Trial in Augusta (CT-011, Gemcitabine)
Terminated
- Pancreatic Neoplasms
- +4 more
- CT-011
- Gemcitabine
-
Augusta, GeorgiaGeorgia Regents University
Jun 18, 2019
Breast Cancer Trial in Italy (Ribociclib, Letrozole, Alpelisib)
Active, not recruiting
- Breast Cancer
- Ribociclib
- +3 more
-
Casale Monferrato, AL, Italy
- +40 more
Dec 3, 2021
Urothelial Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)
Active, not recruiting
- Urothelial Carcinoma
- Pembrolizumab
- +2 more
-
Gilbert, Arizona
- +193 more
Aug 22, 2022
Coronary Artery Disease Trial in Copenhagen (CTA+CTP guided treatment strategy, CTA guided treatment strategy)
Completed
- Coronary Artery Disease
- CTA+CTP guided treatment strategy
- CTA guided treatment strategy
-
Copenhagen, Denmark
- +6 more
Dec 9, 2022
Sacroiliac Joint Unstable Trial in Oslo (CTMA)
Not yet recruiting
- Sacroiliac Joint Unstable
- CTMA
-
Oslo, NorwayUllevål University Hospital
Sep 28, 2023
Advanced Breast Cancer Trial in Worldwide (Ribociclib, fulvestrant, Ribociclib )
Active, not recruiting
- Advanced Breast Cancer
- Ribociclib
- +2 more
-
Mobile, Alabama
- +173 more
Aug 4, 2022
Contrast Enhanced Ultrasound in Human Crohn's Disease-Lumason
Recruiting
- Crohn Disease
- Ultrasound Microbubble Contrast Agent
- Ultrasound Imaging
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Jul 22, 2022
CT Scan and Angiography of Heart to Help Doctors Decide Which
Completed
- Coronary Artery Diseases
- +3 more
- Coronary Angiography
- Computed Tomography (CT) scan
-
Brussel, Belgium
- +5 more
Aug 27, 2019
Relapsed/Refractory Multiple Myeloma Trial in New York, Nashville, Salt Lake City (CB-011)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- CB-011
-
New York, New York
- +3 more
Feb 15, 2023
Proposed Rotational Deformities a Useful Resource
Not yet recruiting
- Lower Limb Deformity
- +3 more
- Gait analysis
- (no location specified)
Oct 10, 2022
Body Mass Index and Metabolic Score for Visceral Adiposity in
Completed
- Visceral Obesity
-
Istanbul, TurkeyIstanbul Goztepe Prof. Dr. Suleyman Yalcin City Hospital
Dec 18, 2022
Hearing Loss, Sensorineural, Bilateral Vestibular Deficiency, DFNA9 Trial in Hasselt (video nystagmography)
Recruiting
- Hearing Loss, Sensorineural
- +3 more
- video nystagmography
-
Hasselt, Limburg, BelgiumJessa Hospital
Mar 29, 2022
Wounds and Injuries, Lacerations, Surgical Incision Trial in Worldwide (MAR-CUTIS, Dermabond Advanced)
Terminated
- Wounds and Injuries
- +2 more
- MAR-CUTIS
- Dermabond Advanced
-
Amiens, France
- +18 more
Aug 10, 2020
Unifying Advanced Treatment With Advanced Imaging
Completed
- Gastrointestinal Stromal Tumor (GIST)
- Dual Energy CT
-
Mannheim, GermanyUniversity Center Mannheim
Apr 6, 2022